Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer.
Hiraki M, Maeda T, Mehrotra N, Jin C, Alam M, Bouillez A, Hata T, Tagde A, Keating A, Kharbanda S, Singh H, Kufe D.
Hiraki M, et al. Among authors: mehrotra n.
Signal Transduct Target Ther. 2018 May 12;3:13. doi: 10.1038/s41392-018-0013-x. eCollection 2018.
Signal Transduct Target Ther. 2018.
PMID: 29760958
Free PMC article.